1. Search results in the navigational tree (All hits)
All the results are highlighted by color in the navigational tree
(at the left-hand side) and remain so until you click on a not highlighted menu item and
thus return to the usual content navigation.
In addition, you can browse through the search results consecutively by pressing the navigational buttons
(
<
1 of
11
>).
Within the text the search result is highlighted by color.
2. Search results by relevance (Top 5)
Following is a list of the 5 most important hits ranked by relevance.
Hint: In the
Help you will find explanations about using search operators in order to conduct an extended search.
In the third quarter of 2013, total revenues of the Merck Serono division increased organically by 3.4%. Including a foreign exchange impact of –6.7%, total revenues decreased by –3.4% to € 1,568 million in comparison with the year-earlier quarter (Q3 2012: € 1,623 million). Despite solid organic growth of 5.2%, negative foreign exchange effects of –7.0% caused the division’s reported sales to decline slightly by –1.8% to € 1,483 million (Q3 2012: € 1,511 million). Organic growth was driven not only by products from the General Medicine, Fertility and Endocrinology business franchises, but also by the oncology drug Erbitux®. In geographic terms, [...]
In the third quarter of 2013, the Merck Millipore division again achieved strong organic sales growth despite a market environment that remained difficult. The 5.9% increase contrasted with changes in foreign exchange rates, which impacted sales by –7.2%. Last year’s acquisition of Biochrom AG, Berlin, increased sales by 0.7%. Overall sales therefore declined slightly by –0.6% to € 639 million (Q3 2012: € 643 million). Currency headwinds stemmed mainly from the Japanese yen and the U.S. dollar. The royalty income generated by products from the Process Solutions and Bioscience business units remained at the previous year’s level of € 6 million. As a [...]
Business in the Performance Materials division again developed very favorably in the third quarter of 2013. Organically, sales declined by only –1.8% compared to the strong year-earlier quarter, thus remaining at a high level. Taking into account currency headwinds of –7.1%, divisional sales decreased by –8.9% to € 406 million (Q3 2012: € 446 million). The foreign exchange impact stemmed mainly from the Japanese yen, the Taiwanese dollar and the U.S. dollar. The Liquid Crystals business unit, which accounts for more than 70% of divisional sales, maintained its high market share. Once again, it defended its market leadership in liquid crystal materials in [...]
Highlights – 3rd Quarter 2013 Accelerated implementation of efficiency measures Solid organic sales growth of ~ 5% Significant increase in EBITDA pre one-time items powered by structural improvements from the “Fit for 2018” transformation program and despite negative currency impacts Merck Serono: Strong organic sales performance of 5.2% driven by Emerging Markets and Japan Consumer Health: Turnaround on track underlined by strong earnings in Q3 2013 Performance Materials: Solid development despite first signs of inventory destocking in the display industry Merck Millipore: Excellent business performance thanks to its balanced portfolio Earnings per share pre [...]
In the third quarter of 2013, the Consumer Health division reported sales of € 131 million, an increase of 7.0% compared to a relatively weak year-earlier quarter (Q3 2012: € 122 million). Organic growth of 14.6% was countered by a negative foreign exchange impact, which lowered sales by –7.6%. All regions contributed to the strong organic growth, with higher sales volumes in both Europe, the division’s largest region in terms of sales, and Emerging Markets driving the overall development. Double-digit sales growth in Germany, France and in the Emerging Markets region more than offset the weak performance of the British subsidiary Seven Seas. In the third [...]
